Clinical Trial Update: Immunotherapy of Cervical Cancer With V3-Cervix [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for immunotherapy V3-Cervix in cervical cancer is reported with an unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• V3-Cervix

Snippet

Sponsor: Immunitor LLC | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN